E-LIB Suche - Ergebnisse für: Oligschlaeger, Yvonne

1

Inhibition of Extracellular Cathepsin D Reduces Hepatic Lip..:

Yadati, Tulasi ; Houben, Tom ; Bitorina, Albert...
Frontiers in Immunology. 12 (2021) - p. , 2021

Link: https://doi.org/10.3389/..

2

Myosteatosis in NAFLD patients correlates with plasma Cathe..:

Ding, Lingling ; De Munck, Toon. J. I. ; Oligschlaeger, Yvonne...
Biomolecular Concepts. 12 (2021) 1 - p. 27-35 , 2021

Link: https://doi.org/10.1515/..

3

The Influence of a Conjugated Pneumococcal Vaccination on P..:

Shiri-Sverdlov, Ronit ; dos Reis, Inês Magro ; Oligschlaeger, Yvonne...
Antioxidants. 10 (2021) 1 - p. 129 , 2021

Link: https://doi.org/10.3390/..

4

Insulin resistance is positively associated with plasma cat..:

Ding, Lingling ; De Munck, Toon. J. I. ; Oligschlaeger, Yvonne...
Biomolecular Concepts. 12 (2021) 1 - p. 110-115 , 2021

Link: https://doi.org/10.1515/..

5

OxLDL as an Inducer of a Metabolic Shift in Cancer Cells:

Bitorina, Albert V. ; Oligschlaeger, Yvonne ; Ding, Lingling...
Journal of Cancer. 12 (2021) 19 - p. 5817-5824 , 2021

Link: https://doi.org/10.7150/..

6

Sex‐opposed inflammatory effects of 27‐hydroxycholesterol a..:

Houben, Tom ; Bitorina, Albert V ; Oligschlaeger, Yvonne...
The Journal of Pathology. 251 (2020) 4 - p. 429-439 , 2020

Link: https://doi.org/10.1002/..

7

Plasma Cathepsin D Activity Rather Than Levels Correlates W..:

Ding, Lingling ; Houben, Tom ; Oligschlaeger, Yvonne...
Frontiers in Endocrinology. 11 (2020) - p. , 2020

Link: https://doi.org/10.3389/..

8

Nonalcoholic Fatty Liver Disease:

, In: Prevention and Treatment of Atherosclerosis; Handbook of Experimental Pharmacology,

Ding, Lingling ; Oligschlaeger, Yvonne ; Shiri-Sverdlov, Ronit. - p. 233-269 , 2020

Link: https://doi.org/10.1007/..

9

NAFLD Preclinical Models: More than a Handful, Less of a Co..:

Oligschlaeger, Yvonne ; Shiri-Sverdlov, Ronit
Biomedicines. 8 (2020) 2 - p. 28 , 2020

Link: https://doi.org/10.3390/..

10

Hematopoietic Npc1 mutation shifts gut microbiota compositi..:

Houben, Tom ; Penders, John ; Oligschlaeger, Yvonne...
Scientific Reports. 9 (2019) 1 - p. , 2019

Link: https://doi.org/10.1038/..

11

Inhibiting Extracellular Cathepsin D Reduces Hepatic Steato..:

Khurana, Princy ; Yadati, Tulasi ; Goyal, Sandeep...
Biomolecules. 9 (2019) 5 - p. 171 , 2019

Link: https://doi.org/10.3390/..

12

Inflammatory Bowel Disease: A Stressed "Gut/Feeling":

Oligschlaeger, Yvonne ; Yadati, Tulasi ; Houben, Tom..
Cells. 8 (2019) 7 - p. 659 , 2019

Link: https://doi.org/10.3390/..

13

Pneumococcal Immunization Reduces Neurological and Hepatic ..:

Houben, Tom ; Magro dos Reis, Inês ; Oligschlaeger, Yvonne...
Frontiers in Immunology. 9 (2019) - p. , 2019

Link: https://doi.org/10.3389/..

14

Plasma cathepsin D activity is negatively associated with h..:

Ding, Lingling ; Goossens, Gijs H. ; Oligschlaeger, Yvonne...
Diabetologia. 63 (2019) 2 - p. 374-384 , 2019

Link: https://doi.org/10.1007/..

15

Low profile high value target: The role of OxLDL in cancer:

Bitorina, Albert V. ; Oligschlaeger, Yvonne ; Shiri-Sverdlov, Ronit.
Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids. 1864 (2019) 12 - p. 158518 , 2019

Link: https://doi.org/10.1016/..